Several resistance mechanisms have been found and thoroughly described including the EGFR T790M mutation, MET proto-oncogene (MET) gene amplification, development of epithelial to mesenchymal transition (EMT), and transition to a small cell lung cancer (SCLC) phenotype [4]. Here, MET is linked to small cell lung carcinoma.